Caudate lobe hepatocellular carcinoma treated with selective chemoembolization.

Hyo-Cheol Kim1, Jin Wook Chung, Hwan Jun Jae

  • 1Department of Radiology, Seoul National University College of Medicine; Institute of Radiation Medicine; Seoul National University Medical Research Center, Seoul, Korea.

Radiology
|August 11, 2010
PubMed
Summary

Selective chemoembolization of the caudate artery improves survival outcomes for patients with caudate lobe hepatocellular carcinoma (HCC). This minimally invasive procedure is a critical factor in achieving longer overall survival and progression-free survival for HCC patients.

Related Concept Videos